Funding Received
$63.1 Million in 4 Rounds from 3 Investors
Most Recent Funding
$30.9 Million Series C on October 18, 2012
Headquarters:
La Jolla, CA
Description:
Cebix is a biopharmaceutical company developing treatments for diabetic complications that affect the function of nerves, kidneys and eyes.
Founders:
Lars Ekman
Categories:
Biotechnology
Website:
http://www.cebix.com

Company Details

Update

Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.

Current Team (6)

Update

Past Team (3)

Update

Funding Rounds (4) - $63.1M

Update

Board Members and Advisors (4)

Update

Investors (3)

Update
  • A72157320397be4c637c4da2b885a5f8

    Sofinnova Ventures

    Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build...
  • Bb3d6fbd0e442789b59061f392f8ad0d

    InterWest Partners

    InterWest invests an average of about $7 - 15 million over the span of their involvement with...
  • 14d02e49306a86268b17b93e9374b9a2

    Thomas, McNerney & Partners

    Thomas, McNerney & Partners is a health care venture capital firm with approximately $600...

Offices/Locations (1)

Update
  • Office

    1298 Prospect Street

    Suite 2A

    La Jolla, CA 92037

    USA